IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revelation Capital Management, LLC

Q3 2026 Holdings

Filed 2026-11-02 | 2 holdings | $8.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Obsidian Therapeutics Inc(OBX)COM67448A106$5.9M428,34673.4%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$2.1M299,31126.6%